Document is current
Any future updates will be listed below
-
Authors
Zheng, Sean L. https://orcid.org/0000-0002-5762-6392
Jurgens, Sean J. https://orcid.org/0000-0002-1605-9782
McGurk, Kathryn A. https://orcid.org/0000-0002-5445-6906
Xu, Xiao
Grace, Chris
Theotokis, Pantazis I. https://orcid.org/0000-0001-8718-230X
Buchan, Rachel J. https://orcid.org/0000-0003-2490-9289
Francis, Catherine
de Marvao, Antonio https://orcid.org/0000-0001-9095-5887
Curran, Lara
Bai, Wenjia https://orcid.org/0000-0003-2943-7698
Pua, Chee Jian https://orcid.org/0000-0003-4683-3043
Tang, Hak Chiaw
Jorda, Paloma https://orcid.org/0000-0002-9236-1713
van Slegtenhorst, Marjon A.
Verhagen, Judith M. A. https://orcid.org/0000-0002-0340-3433
Harper, Andrew R.
Ormondroyd, Elizabeth https://orcid.org/0000-0002-9116-4064
Chin, Calvin W. L. https://orcid.org/0000-0002-9867-4390
,
de Marvao, Antonio
van Slegtenhorst, Marjon A.
Ware, James S.
Pantazis, Antonis
Baksi, John
Halliday, Brian P.
Matthews, Paul https://orcid.org/0000-0002-1619-8328
Pinto, Yigal M. https://orcid.org/0000-0002-2836-571X
Walsh, Roddy https://orcid.org/0000-0001-5092-8825
Amin, Ahmad S. https://orcid.org/0000-0002-1600-7907
Wilde, Arthur A. M.
Cook, Stuart A.
Prasad, Sanjay K.
Barton, Paul J. R. https://orcid.org/0000-0002-1165-7767
O’Regan, Declan P.
Lumbers, R. T. https://orcid.org/0000-0002-9077-4741
Goel, Anuj
Tadros, Rafik https://orcid.org/0000-0002-1472-0258
Michels, Michelle
Watkins, Hugh https://orcid.org/0000-0002-5287-9016
Bezzina, Connie R. https://orcid.org/0000-0002-0633-3514
Ware, James S. https://orcid.org/0000-0002-6110-5880
- License Information
-
More Information
Article History
Received: 30 March 2023
Accepted: 21 January 2025
First Online: 18 February 2025
Competing interests
: S.L.Z. has acted as a consultant for Health Lumen. R.T.L. has acted as a consultant for Health Lumen and Fitfile, and received funding from Pfizer. J.S.W. has acted as a consultant for MyoKardia, Pfizer, Foresite Labs and Health Lumen, and received institutional support from Bristol Myers Squibb and Pfizer. M.M. has received research support or consultancy fees from Bristol Myers Squibb, Cytokinetics, Pfizer, Sanofi Genzyme, Biomarin and Alnylam. The remaining authors declare no competing interests.
